Loading…
Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke
Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihyperte...
Saved in:
Published in: | Journal of Nepal Medical Association 2015-03, Vol.53 (197), p.5-11 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3 |
---|---|
cites | |
container_end_page | 11 |
container_issue | 197 |
container_start_page | 5 |
container_title | Journal of Nepal Medical Association |
container_volume | 53 |
creator | Poudel, R S Thapa, L Shrestha, S Khatiwada, D Upadhyay, N Bhandari, T R Shrestha, A |
description | Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients.
The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis.
Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients.
The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke. |
doi_str_mv | 10.31729/jnma.2696 |
format | article |
fullrecord | <record><control><sourceid>pubmed_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210</doaj_id><sourcerecordid>26983040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEgvFx4QegnBEdSdomzXEaAyYhcQAkbpWTOpBB2ynpkPbvyTbYxZbtx6_sl5BLzsY5V0LfLroWxkJqeUBGvOJlJpV4PyQjxkSVCcXLE3Ia44KxgquyPCYnia1yVrARgZlz3oJd097Rad8a32FDJ93gh8-Qyn7w9oa-DDD4LlLodrPscb3EMGAX_Q_Su7D6iNR3dGJXA9J5tJ_Yepu2Qv-F5-TIwXfEi798Rt7uZ6_Tx-zp-WE-nTxllsuSZbpsTL45uFQ55tZx1KWRnCvgkglRJcgVplAAThfKGlMhayTmAoBpbW1-RuY73aaHRb0MvoWwrnvw9bbRh48aQvrmG2tpJStclRaxKaRGrVJswFaNASM4S1rXOy0b-hgDur0eZ_XW83rjeb3xPMFXO3i5Mi02e_Tf5PwX8SB8_w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><source>IngentaConnect Journals</source><creator>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</creator><creatorcontrib>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</creatorcontrib><description>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients.
The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis.
Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients.
The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</description><identifier>ISSN: 0028-2715</identifier><identifier>EISSN: 1815-672X</identifier><identifier>DOI: 10.31729/jnma.2696</identifier><identifier>PMID: 26983040</identifier><language>eng</language><publisher>Nepal: Nepal Medical Association</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antihypertensive Agents - therapeutic use ; antihypertensive; anti-thrombotic; efficacy ; statins; stroke ; Brain Ischemia - diagnosis ; Brain Ischemia - drug therapy ; Brain Ischemia - mortality ; Cross-Sectional Studies ; Drug Therapy, Combination ; Female ; Fibrinolytic Agents - therapeutic use ; Follow-Up Studies ; Hospitals, University ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Male ; Middle Aged ; Nepal ; Prospective Studies ; Risk Factors ; Severity of Illness Index ; Stroke - diagnosis ; Stroke - drug therapy ; Stroke - mortality ; Survival Analysis ; Treatment Outcome</subject><ispartof>Journal of Nepal Medical Association, 2015-03, Vol.53 (197), p.5-11</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26983040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poudel, R S</creatorcontrib><creatorcontrib>Thapa, L</creatorcontrib><creatorcontrib>Shrestha, S</creatorcontrib><creatorcontrib>Khatiwada, D</creatorcontrib><creatorcontrib>Upadhyay, N</creatorcontrib><creatorcontrib>Bhandari, T R</creatorcontrib><creatorcontrib>Shrestha, A</creatorcontrib><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><title>Journal of Nepal Medical Association</title><addtitle>JNMA J Nepal Med Assoc</addtitle><description>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients.
The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis.
Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients.
The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>antihypertensive; anti-thrombotic; efficacy ; statins; stroke</subject><subject>Brain Ischemia - diagnosis</subject><subject>Brain Ischemia - drug therapy</subject><subject>Brain Ischemia - mortality</subject><subject>Cross-Sectional Studies</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Follow-Up Studies</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nepal</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Stroke - diagnosis</subject><subject>Stroke - drug therapy</subject><subject>Stroke - mortality</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0028-2715</issn><issn>1815-672X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9kE1PwzAMhiMEgvFx4QegnBEdSdomzXEaAyYhcQAkbpWTOpBB2ynpkPbvyTbYxZbtx6_sl5BLzsY5V0LfLroWxkJqeUBGvOJlJpV4PyQjxkSVCcXLE3Ia44KxgquyPCYnia1yVrARgZlz3oJd097Rad8a32FDJ93gh8-Qyn7w9oa-DDD4LlLodrPscb3EMGAX_Q_Su7D6iNR3dGJXA9J5tJ_Yepu2Qv-F5-TIwXfEi798Rt7uZ6_Tx-zp-WE-nTxllsuSZbpsTL45uFQ55tZx1KWRnCvgkglRJcgVplAAThfKGlMhayTmAoBpbW1-RuY73aaHRb0MvoWwrnvw9bbRh48aQvrmG2tpJStclRaxKaRGrVJswFaNASM4S1rXOy0b-hgDur0eZ_XW83rjeb3xPMFXO3i5Mi02e_Tf5PwX8SB8_w</recordid><startdate>20150331</startdate><enddate>20150331</enddate><creator>Poudel, R S</creator><creator>Thapa, L</creator><creator>Shrestha, S</creator><creator>Khatiwada, D</creator><creator>Upadhyay, N</creator><creator>Bhandari, T R</creator><creator>Shrestha, A</creator><general>Nepal Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20150331</creationdate><title>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</title><author>Poudel, R S ; Thapa, L ; Shrestha, S ; Khatiwada, D ; Upadhyay, N ; Bhandari, T R ; Shrestha, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>antihypertensive; anti-thrombotic; efficacy ; statins; stroke</topic><topic>Brain Ischemia - diagnosis</topic><topic>Brain Ischemia - drug therapy</topic><topic>Brain Ischemia - mortality</topic><topic>Cross-Sectional Studies</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Follow-Up Studies</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nepal</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Stroke - diagnosis</topic><topic>Stroke - drug therapy</topic><topic>Stroke - mortality</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poudel, R S</creatorcontrib><creatorcontrib>Thapa, L</creatorcontrib><creatorcontrib>Shrestha, S</creatorcontrib><creatorcontrib>Khatiwada, D</creatorcontrib><creatorcontrib>Upadhyay, N</creatorcontrib><creatorcontrib>Bhandari, T R</creatorcontrib><creatorcontrib>Shrestha, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Directory of Open Access Journals</collection><jtitle>Journal of Nepal Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poudel, R S</au><au>Thapa, L</au><au>Shrestha, S</au><au>Khatiwada, D</au><au>Upadhyay, N</au><au>Bhandari, T R</au><au>Shrestha, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke</atitle><jtitle>Journal of Nepal Medical Association</jtitle><addtitle>JNMA J Nepal Med Assoc</addtitle><date>2015-03-31</date><risdate>2015</risdate><volume>53</volume><issue>197</issue><spage>5</spage><epage>11</epage><pages>5-11</pages><issn>0028-2715</issn><eissn>1815-672X</eissn><abstract>Anti-thrombotic, statins and antihypertensive drugs are commonly used for the management of acute ischemic stroke in Nepal but there is no evidence regarding their efficacy in our context. This study aims to explore the efficacy of these combined medications (anti-thrombotic, statins and antihypertensive drugs) in acute ischemic stroke patients for the first time and to assess the risk factors present in those patients.
The study was conducted on 37 acute ischemic stroke patients admitted and treated at the Neurology Department of College of Medical Sciences-Teaching Hospital, Chitwan, Nepal and they were followed at three months (90±10 days). The initial stroke severity and functional disability were evaluated at admission and at 3 months using National Institute of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) respectively. The outcome parameters were functional independence (mRS≤2) and mortality at three months (mRS=6). Frequency distribution, Mann-Whitney U-test and χ2 test were performed for statistical analysis.
Out of 37 patients, 27 (73%) were Smoker, 22 (59.5%) had hypertension and 19 (51.4%) were alcohol consumer. The stroke severity on admission was statistically significant with functional independence (P=0.003) and mortality (P=0.015) at three month. Similarly, Rankin grade on admission was statistically significant with functional independence (P=0.001) and mortality (P=0.048) at three month. At three months, 20 (69%) survived patients were independent while mortality was seen in eight (21.6%) patients.
The management of acute ischemic stroke with combined anti-thrombotic, statins and antihypertensive drugs seems promising and efficacious in mild to moderately severe ischemic stroke.</abstract><cop>Nepal</cop><pub>Nepal Medical Association</pub><pmid>26983040</pmid><doi>10.31729/jnma.2696</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-2715 |
ispartof | Journal of Nepal Medical Association, 2015-03, Vol.53 (197), p.5-11 |
issn | 0028-2715 1815-672X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_6c604f8a09ed469e97469dac8dbab210 |
source | IngentaConnect Journals |
subjects | Adult Aged Aged, 80 and over Antihypertensive Agents - therapeutic use antihypertensive anti-thrombotic efficacy statins stroke Brain Ischemia - diagnosis Brain Ischemia - drug therapy Brain Ischemia - mortality Cross-Sectional Studies Drug Therapy, Combination Female Fibrinolytic Agents - therapeutic use Follow-Up Studies Hospitals, University Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Male Middle Aged Nepal Prospective Studies Risk Factors Severity of Illness Index Stroke - diagnosis Stroke - drug therapy Stroke - mortality Survival Analysis Treatment Outcome |
title | Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A45%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Combined%20Antithrombotic,%20Statins%20and%20Anti-Hypertensive%20Drugs%20in%20Acute%20Ischemic%20Stroke&rft.jtitle=Journal%20of%20Nepal%20Medical%20Association&rft.au=Poudel,%20R%20S&rft.date=2015-03-31&rft.volume=53&rft.issue=197&rft.spage=5&rft.epage=11&rft.pages=5-11&rft.issn=0028-2715&rft.eissn=1815-672X&rft_id=info:doi/10.31729/jnma.2696&rft_dat=%3Cpubmed_doaj_%3E26983040%3C/pubmed_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1650-95db30028573e3cf1e95b6117a160228165f4b47aaf947cbb8e0d6e32aa099cc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26983040&rfr_iscdi=true |